BR vs IRD · P/E 16, rev $6.89B vs rev $11.0M
Broadridge Financial Solutions Inc (BR) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. IRD currently screens at market cap $35.7M.
Not investment advice. Open the BR and IRD stock pages for the full models.
Not investment advice.